Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Toxicon : Official Journal of the International Society on Toxinology|November 14, 2006
Gating modifier toxins of voltage-gated calcium channelsStefan I McDonoughCurrent Drug Targets. CNS and Neurological Disorders|December 8, 2004
Voltage-gated calcium channels as targets for the treatment of chronic painJoseph G McGivern, Stefan I McDonoughCurrent Pharmaceutical Design|September 11, 2008
Peptides targeting voltage-gated calcium channelsRaymond S Norton, Stefan I McDonoughJournal of Neurophysiology|June 18, 2004
Alternative splicing in the voltage-sensing region of N-Type CaV2.2 channels modulates channel kineticsYingxin Lin, Stefan I McDonough, Diane LipscombePsychiatry Research|June 26, 2021
Rare germline variants in individuals diagnosed with schizophrenia within multiplex familiesShangzhong Li, Lynn E DeLisi, Stefan I McDonoughBiophysical Journal|October 27, 2004
FPL 64176 modification of Ca(V)1.2 L-type calcium channels: dissociation of effects on ionic current and gating currentStefan I McDonough, Yasuo Mori, Bruce P BeanThe Journal of General Physiology|April 4, 2002
Interactions among toxins that inhibit N-type and P-type calcium channelsStefan I McDonough, Linda M Boland, Isabelle M Mintz, et al.Journal of Medicinal Chemistry|February 19, 2016
Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1Justin K Murray, Jason Long, Anruo Zou, et al.Bioorganic & Medicinal Chemistry Letters|February 7, 2012
The discovery of aminopyrazines as novel, potent Na(v)1.7 antagonists: hit-to-lead identification and SARHoward Bregman, Hanh Nho Nguyen, Elma Feric, et al.Bioorganic & Medicinal Chemistry Letters|February 10, 2012
Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Na(v)1.7 antagonistsNagasree Chakka, Howie Bregman, Bingfan Du, et al.Pageof 3